PATENT CLAIM ANALYSIS

Application Number: 15873762
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "282000"]

Abstract:
Methods are provided for attenuating or preventing μ-opioid receptor mediated tolerance and opioid-induced hyperalgesia in a subject in need of acute or chronic opioid treatment for pain or in need of opioid anesthesia.

Claim (Index 7):
A pharmaceutical composition comprising at least one peripherally acting \u03bc-opioid receptor antagonist and at least one \u03bc-opioid receptor agonist for use in the preparation of a kit or medicament for attenuating or preventing \u03bc-opioid receptor mediated tolerance or opioid-induced hyperalgesia in a subject in need of acute or chronic opioid treatment for pain OR in need of general anesthesia, wherein ab initio administration of a therapeutically effective amount of the kit or medicament to the subject attenuates or prevents symptoms generally associated with \u03bc-opioid receptor mediated tolerance or opioid-induced hyperalgesia.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.30769
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10319789', '13560620', '13189954', '14246847', '13076386']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7851219488901535
- 35 USC 102 Novelty (BERT): 0.5442622934231607
- Combined Prediction Score: 0.7610359833434543
- Mean Citation Score: 344.695056
- Max Citation Score: 414.39047
- Similarity Product: 281.3840306185746

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test